Latest "Life Science Intelligence (LSI)®" News Stories

18:16 EDT 22nd March 2019 | BioPortfolio

Here are the most relevant search results for "Life Science Intelligence (LSI)®" found in our extensive news archives from over 250 global news sources.

More Information about Life Science Intelligence (LSI)® on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Life Science Intelligence (LSI)® for you to read. Along with our medical data and news we also list Life Science Intelligence (LSI)® Clinical Trials, which are updated daily. BioPortfolio also has a large database of Life Science Intelligence (LSI)® Companies for you to search.

Showing "Life Science Intelligence" News Articles 1–25 of 15,000+

Friday 22nd March 2019

Sanofi: FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin)

FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin) PARIS and THE WOODLANDS, TX -  March 22, 2019 -  The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the New Drug Application for investigational Zynquista(TM) (sotagliflozin)*, a dual SGLT1 and SGLT2 inhibitor for the treatment of adults with type 1 diabetes in combi...

Medicrea Reports 2018 Annual Results

2018 Annual Sales: € 32.3M, +22% at Constant Exchange RateStrong Growth of UNiD® Surgeries in the USA: +67%Gross Margin Jumping to 77% in the 4th QuarterEBITDA at Break-Even in H2 2018Positive EBITDA Expected for 2019 A Unique Model in Patient-Specific Spine Surgery Based on Artificial Intelligence and Large Industrial Capacity The M...

Life Science Big News Roundup: RISE Announces Hemp-based CBD Products for Sports Recovery and PMS; Kalytera Reports Data for First Cohort in Phase 2 Clinical Study

In case you missed it, here is this week’s life science big news roundup. The post Life Science Big News Roundup: RISE Announces Hemp-based CBD Products for Sports Recovery and PMS; Kalytera Reports Data for First Cohort in Phase 2 Clinical Study appeared first on Investing News Network.

Researchers Identify Gene Variant Associated With Cellular Aging

NewsA new study shows that a gene mutation interacts with multiple types of psychiatric stress including post-traumatic stress disorder (PTSD), pain and sleep disturbances in association with cellular aging.

Biogen and Eisai remain committed after discontinuation of ENGAGE and EMERGE programmes

22 March 2019 – Pharmaceutical companies Biogen and Eisai have announced the discontinuation of two Phase 3 trials of aducanumab. The decision came after analysis by an independent monitoring committee indicated the trials were unlikely to succeed. Biogen and Eisai will continue to investigate other treatments for Alzheimer’s disease, including anti-amyloid treatment BAN2401....

Genomics England signs immunotherapy partnership with CCG

NHS England spin-out Genomics England and artificial intelligence (AI)-focused Cambridge Cancer Genomics (CCG) have announced they have entered into an...Read More... The post Genomics England signs immunotherapy partnership with CCG appeared first on Pharmaceutical Technology.

Healthcare Analytics Leaders Clinigence and QualMetrix Merge to Accelerate Value-Based Care and Population Health Management

Clinigence, LLC and QualMetrix, Inc., two pioneering healthcare information technology companies providing advanced, cloud-based platforms that enable healthcare organizations to shift to value-based care reimbursements and to provide population health management, today announced that they have completed their merger. The merged entity has become a wholly-...

It takes two: ‘No clinical AI solution can work on its own’

Clinical AI, no matter how sophisticated, cannot work on its own, says Life Image CEO, who predicts that CROs will either adapt or be disrupted by smaller companies with digital access capabilities.

Xpediant Digital Hires Steve Surace as VP of Product Development

Based on Product Demands, Xpediant expands Leadership Team with VP of Product Development HOUSTON, Texas (PRWEB) March 22, 2019 Xpediant Digital, the leader in DAM Integration Platforms, today announced that veteran technology leader Steve Surace has joined Xpediant as VP of Product Development. Surace has spent his career developing products, building complex solutions and world-class global tea...

Cells Undergo Past Life Regression:

Cells Undergo Past Life Regression:

OncLive® Presents State of the Science Summit™ on Ovarian Cancer and Soft Tissue Sarcoma

The summit will feature expert faculty from Memorial Sloan Kettering Cancer Center OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, will host its latest State of the Science Summit™ on ovarian cancer and soft tiss...

Cells Undergo Past Life Regression

Adult cells can recover the memories of their past lives, developmental stage by developmental stage, going all the way back to their embryonic origins. This cell-level exercise in past life regression does not require that cells be mesmerized. Rather, cells can have their enhancer DNA examined for suppressive epigenetic modifications, which amount to an archive […] The post Cells Undergo Pa...

Brain-inspired AI Inspires Insights About the Brain

NewsCan artificial intelligence help us understand how the brain understands language? Contributed Author: 

Mayo Clinic study identifies potential new drug therapy for liver diseases

Drug therapy may effectively treat a potentially life-threatening condition associated with cirrhosis and other chronic liver diseases, according to a new study by Mayo Clinic researchers.

Managing MS

FRIDAY, March 22, 2019 -- Proper treatment can help people with multiple sclerosis (MS) contend with their disease, an expert says. "Patients get a predisposed feeling that their life is doomed. That it's going to be a complicated life, which isn't...

Magnetic Stir Bars Carry 'Memory' From Previous Flasks, Tubes

NewsHigh level of surface contaminations of magnetic stir bars brings highly reactive traces of metal species from previous experiments to the next ones.

USAWorldMeds Names Neurologist & Addiction Medicine Specialist Dr. Russell Surasky as Expert Speaker for New Ground-Breaking Medication Lucemyra

Lucemyra is the First FDA Approved Medicine to Treat Opioid Withdrawal Syndrome (OWS). GREAT NECK. N.Y. (PRWEB) March 22, 2019 “Not a day goes by when we don’t learn more about the devastation caused by opioid addiction. Every day in the United States approximately 4,000 individuals start using opiates for non-medical purposes. We are now up to about 130 opioid overdoses per day,” says Neur...

Quality of palliative pain relief better with specialist nurses

Patients at home who are approaching the end-of-life experience substantially better pain relief if they receive specialist palliative care from a nurse, according to researchers.

uBiome Awards Grant to Nnamdi Azikiwe University to Study the Influence of Probiotics on the Urinary Tract Microbiome

Researchers will use the grant to investigate the effect of probiotics on the urinary tract microbiome. SAN FRANCISCO (PRWEB) March 22, 2019 uBiome has awarded microbiome research support in study design, planning, sample collection, and analysis to a team of researchers at Nnamdi Azikiwe University in Anambra State, Nigeria led by Dr. Kingsley C. Anukam, PhD, and supported by Dr. Nneka R. Agboko...

SoFi and Delos Partner to Bring Delos’ Home Wellness Solutions to Homeowners

The partnership will help drive accessibility of Delos’ health and wellness technology to homes across the U.S. Wellness real estate and technology company, Delos™, is collaborating with online personal finance company, SoFi, to ensure homeowners will have an accessible financing path to implement Delos’ DARWIN Home Wellness Intelligence Network,...

Paediatrician who “groomed a community” to conceal child abuse is sentenced to 79 years

A Pennsylvania paediatrician whose medical licence was revoked 19 years ago—then reinstated after a local campaign—will spend the rest of his life in prison after being convicted in the abuse of 31...

MassRoots Adds Robert Hymers to Its Strategic Advisory Board

MassRoots, Inc. ("MassRoots" or the "Company") (OTCQB: MSRT), a leading technology platform for the regulated cannabis industry, is pleased to announce it has added cannabis industry veteran Mr. Robert L. Hymers to its Strategic Advisory Board. In this capacity, Mr. Hymers is expected to help guide MassRoots’ strategic investments and partne...

The Dark Side Of Artificial Intelligence: Increased Efficiency Comes With Ominous Threat Of Vulnerability To Hackers

A report warns that artificial intelligence can be easily duped with tiny pieces of data. The authors say bad actors could hack into records and make it seem like there's an illness there that isn't. But more likely is that doctors, hospitals and other organizations could manipulate the A.I. in billing or insurance software in an effort to maximize the money coming their way. In other health techn...

Cardiology as a "Collision Point" between Consumer IT and the Healthcare System

In a recent tweet, Matthew Herper, who covers science and medicine for Forbes, pointed out that cardiology will be an important "collision" point between consumer IT and the practice of medicine. He's right on target as I have emphasized in a recent note about the importance of clinical information being...

Sherlock Biosciences licenses Wyss technology to create affordable molecular diagnostics

Named INSPECTR, it was created by a team led by Wyss Core Faculty Member Jim Collins, Ph.D., who is also the Termeer Professor of Medical Engineering & Science The post Sherlock Biosciences licenses Wyss technology to create affordable molecular diagnostics appeared first on Compelo Medical Devices - Latest industry news and analysis.

Quick Search


News Quicklinks